AgingResearch.News
medRxiv

Proteomic markers of colorectal cancer risk: results from the European Prospective Investigation into Cancer and Nutrition

By M. A. Lee, V. Viallon, D. C. Muller, Show 24 more authorsM. J. Gunter
Figure 1. Circulating protein associations with incident colorectal, colon, and rectal cancer risk in EPIC.
Open the figure at full size
Figure 1. Circulating protein associations with incident colorectal, colon, and rectal cancer risk in EPIC.Circulating protein associations with incident colorectal, colon, and rectal cancer risk in EPIC.Lee et al., CC BY
Preprint: cohort study of 658 peopleBiomarkers

Independent replication

Paper

Abstract

Background: Circulating proteins are promising biomarkers of colorectal cancer risk. Most studies combine colon and rectal cancer despite their biological differences.

The paper

M. A. Lee, V. Viallon, D. C. Muller, Show 24 more authorsM. J. Gunter

International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France

medRxiv, 7 Oct 2026, CC BY, Preprint, not peer-reviewed

doi.org/10.64898/2026.10.05.26364761

More on GDF-15